Drawing for SOFIA

USPTO serial 79434011

SOFIA

Reviewed by CopyMark Law Group

Status 653
Filing date
Status date
Registration date
—
Examiner
MORRIS, KRISTINA KLOIBER
Law office
TMO LAW OFFICE 116

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with SOFIA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Max Vern

Max Vern Amster, Rothstein & Ebenstein LLP405 Lexington AvenueNew York, NY 10174United States

Goods and services

ClassDescriptionStatusFirst use
009Artificial intelligence software; artificial intelligence software for monitoring; artificial intelligence software for analysis; data processing software in the fields of health, biotechnology, digital medicine and sustainable technologies; downloadable artificial intelligence computer software for data analysis; interactive software based on artificial intelligence; all the aforesaid goods exclusively relate to artificial intelligence software designed for the processing and analysis of scientific, medical and biotechnological data, based on scientific and research databases, especially scientific publications, research data, clinical trials, patents, research institutions and innovation actors in the field of life sciences; all the aforesaid goods excluded from clinical laboratory analyzers, medical diagnostic analyzers or any other body fluid diagnostic application.ACTIVE—
035Scientific, medical, biotechnological and economic data processing services; economic data analysis services, the aforementioned services exclusively relate to artificial intelligence software designed for the analysis and processing of scientific, medical and biotechnological data, based on scientific and research databases, especially scientific publications, research data, clinical trials, patents, research institutions and innovation actors in the field of life sciences.ACTIVE—
036Financial analysis services; the aforementioned services exclusively relate to artificial intelligence software designed for scientific, medical and biotechnological data processing and analysis, based on scientific and research databases, especially scientific publications, research data, clinical trials, patents, research institutions and innovation actors in the field of life sciences.ACTIVE—
042Design, development, provision and maintenance of artificial intelligence software; providing online non-downloadable chatbot software for simulating conversations; providing temporary use of non-downloadable software (SaaS) in the fields of health, biotechnology, digital medicine and venture capital; research, design and development of software using artificial intelligence; research and development services with respect to artificial intelligence technology; research, design and development of computer software using artificial intelligence; scientific, medical and biotechnological data analysis services; the aforementioned services exclusively relate to artificial intelligence software designed for scientific, medical and biotechnological data processing and analysis, based on scientific and research databases, especially scientific publications, research data, clinical trials, patents, research institutions and innovation actors in the field of life sciences; all the aforementioned services excluded from clinical laboratory analyzers, medical diagnostic analyzers or any other body fluid diagnostic application.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 15, 2026LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Jul 14, 2026GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jul 14, 2026GNSLLETTER OF SUSPENSION E-MAILED—
Jul 14, 2026CNSLSUSPENSION LETTER WRITTEN—
Jun 5, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 5, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 5, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 30, 2026LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Dec 25, 2025RFNTREFUSAL PROCESSED BY IB—
Dec 10, 2025RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Dec 10, 2025RFRRREFUSAL PROCESSED BY MPU—
Nov 2, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Nov 1, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 17, 2025DOCKASSIGNED TO EXAMINER—
Oct 5, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 5, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 2, 2025REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance